Low Versus High Pressure Suction Drainage After Total Knee Arthroplasty

"Low Versus High Pressure Suction Drainage After Total Knee Arthroplasty: a Double Blind Randomized Controlled Trial"

Principal hypothesis:

A low suction drainage (-50 mmHg) reduce a 25% the blood loss with respect a standard closed drainage (-700 mmHg) following total knee arthroplasty.

Study Overview

Detailed Description

Secondary's hypothesis:

  • It don't expect differences in:

    1. Incidence of hematomas
    2. Incidence in surgery wound infection
    3. Time of immobilization
    4. Duration of hospitalization
  • The low suction drainage (-50 mmHg) will be more cost-effective than the standard closed drainage (-700 mmHg)

Study Type

Interventional

Enrollment (Actual)

169

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Catalunya
      • Barcelona, Catalunya, Spain, 08025
        • Hospital de la Santa Creu i Sant Pau
      • Barcelona, Catalunya, Spain, 08025
        • Orthopedic and Traumatology Service. Hospital de la Santa Creu i Sant Pau.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult knee replacement patients who agreed to participate in the study

Exclusion Criteria:

  • People that not accomplished the inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low suction drainage
In the experimental group the drainage catheter was connected to a modified DRENOFAST® system. This system consisted of a sterile plastic bottle with a holding capacity of 600 mL of fluid and a negative pressure of 700mmHg. It was hermetically closed and had two connections. The DRENOFAST® modification consisted of establishing an open connection between the bottle and a wall vacuum source (normally used to administer oxygen) placed next to the patient's bed. The 50 mmHg constant negative pressure of the bottle was maintained by the wall vacuum source and verified by flow meter.
In the experimental group the drainage catheter was connected to a modified DRENOFAST® system. This system consisted of a sterile plastic bottle with a holding capacity of 600 mL of fluid and a negative pressure of 700mmHg. It was hermetically closed and had two connections. The DRENOFAST® modification consisted of establishing an open connection between the bottle and a wall vacuum source (normally used to administer oxygen) placed next to the patient's bed. The 50 mmHg constant negative pressure of the bottle was maintained by the wall vacuum source and verified by flow meter. Duration: Drains were removed after bleeding had ceased (48-72h).
Other Names:
  • DRENOFAST® modified
Active Comparator: High suction drainage
The standard DRENOFAST® system was used in the control group, and the initial negative pressure was 700 mmHg.
In order to mask the type of intervention from the patient and the investigators, both drainage systems had two drain catheters. One catheter allowed the blood to flow from the wound to the bottle. The second catheter connected the bottle to the vacuum source. In the experimental arm the second catheter was open, while in the control group it was closed. So that the system used could not be distinguished, the connection of the second catheter to the bottle was covered with opaque adhesive tape.Drains were removed after bleeding had ceased.
Other Names:
  • DRENOFAST® system

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
total post-surgical blood loss (mL)
Time Frame: from the moment after surgery until drainage catheter removal
from the moment after surgery until drainage catheter removal

Secondary Outcome Measures

Outcome Measure
Time Frame
blood loss (mL) in the recovery unit
Time Frame: 24-48 h
24-48 h
Blood loss in the ward
Time Frame: 5-10 days
5-10 days
need for a blood transfusion according to the surgeon's criteria
Time Frame: 10 days
10 days
number of blood units required for transfusion
Time Frame: 10 Days
10 Days
post-surgical pain (using a 100mm visual analogue scale)
Time Frame: 10 days
10 days
incidence of hematomas
Time Frame: 10 days
10 days
infections
Time Frame: 10 days
10 days
suture dehiscence
Time Frame: 10 days
10 days
re-intervention due to complications in the surgical wound
Time Frame: 10 dasy
10 dasy
venous thrombosis
Time Frame: 10 days
10 days
hypotension
Time Frame: 10 days
10 days
mortality
Time Frame: 10 days
10 days
adverse reactions
Time Frame: 10 days
10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Calvo Rafael, Rn, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2006

Primary Completion (Actual)

March 1, 2007

Study Completion (Actual)

March 1, 2007

Study Registration Dates

First Submitted

March 19, 2009

First Submitted That Met QC Criteria

March 19, 2009

First Posted (Estimate)

March 20, 2009

Study Record Updates

Last Update Posted (Estimate)

March 20, 2009

Last Update Submitted That Met QC Criteria

March 19, 2009

Last Verified

March 1, 2009

More Information

Terms related to this study

Other Study ID Numbers

  • DRENAJE50MMHG/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Knee Arthroplasty

Clinical Trials on low pressure suction drainage

Subscribe